KIND-1
NIRRHe001-A
General
Cell Line |
|
hPSCreg name | NIRRHe001-A |
Cite as: | NIRRHe001-A (RRID:CVCL_B234) |
Alternative name(s) |
KIND-1
|
Cell line type | Human embryonic stem cell (hESC) |
Similar lines | No similar lines found. |
Last update | 3rd September 2022 |
User feedback | |
Provider |
|
Generator |
National Institute for Research in Reproductive Health (NIRRH)
Contact:
Research in Reproductive Health |
Derivation country | India |
External Databases |
|
Cellosaurus | CVCL_B234 |
Wikidata | Q54930615 |
General Information |
|
Publications |
|
* Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases |
Ethics
Alternatives to consent are available? | Yes |
Alternatives to consent | |
Alternative consent approval number | |
How may genetic information associated with the cell line be accessed? |
hESC Derivation
Embryo stage | Blastula with ICM and Trophoblast |
Supernumerary embryos from IVF treatment? |
Yes
|
ZP removal technique | Enzymatic |
Cell isolation | Mechanical |
Culture Conditions
Feeder cells |
human foreskin fibroblast Cellfinder Ont Id: CELDA_000001419 |
|||||||||
CO2 Concentration | 5 % | |||||||||
Medium |
Other medium:
Base medium: Knockout-DMEM
Main protein source: Knock-out serum replacement Serum concentration: 20 % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
|
|||
ZFP42 (REX-1) |
Yes |
|
||||
SOX2 |
Yes |
|
||||
TERT |
Yes |
|
||||
Alkaline Phosphatase |
Yes |
|
||||
SSEA-1 |
No |
|
||||
SSEA-3 |
Yes |
|
||||
SSEA-4 |
Yes |
|
||||
TRA 1-60 |
Yes |
|
||||
TRA 1-81 |
Yes |
|
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46XX
Passage number: 40
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.